Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35


Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, Santander C, Schoepfer AM, Storr MA, Terreehorst I, Straumann A, Attwood SE.

United European Gastroenterol J. 2017 Apr;5(3):335-358. doi: 10.1177/2050640616689525. Epub 2017 Jan 23. Review.


Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.

Krohn RM, Parsons SA, Fichna J, Patel KD, Yates RM, Sharkey KA, Storr MA.

J Inflamm (Lond). 2016 Jul 14;13:21. doi: 10.1186/s12950-016-0129-0. eCollection 2016.


Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission.

Fichna J, Poole DP, Veldhuis N, MacEachern SJ, Saur D, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Małecka-Panas E, Krajewska WM, Liedtke W, Steinhoff MS, Timmermans JP, Bunnett NW, Sharkey KA, Storr MA.

J Mol Med (Berl). 2015 Dec;93(12):1297-309. doi: 10.1007/s00109-015-1336-5. Epub 2015 Sep 2.


Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.

Bashashati M, Nasser Y, Keenan CM, Ho W, Piscitelli F, Nalli M, Mackie K, Storr MA, Di Marzo V, Sharkey KA.

Br J Pharmacol. 2015 Jun;172(12):3099-111. doi: 10.1111/bph.13114. Epub 2015 Apr 23.


AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.

Keenan CM, Storr MA, Thakur GA, Wood JT, Wager-Miller J, Straiker A, Eno MR, Nikas SP, Bashashati M, Hu H, Mackie K, Makriyannis A, Sharkey KA.

Br J Pharmacol. 2015 May;172(9):2406-18. doi: 10.1111/bph.13069. Epub 2015 Feb 27.


Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Bashashati M, Hejazi RA, Andrews CN, Storr MA.

Can J Gastroenterol Hepatol. 2014 Jun;28(6):335-41. Epub 2014 Apr 9.


Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.

Fichna J, Sałaga M, Stuart J, Saur D, Sobczak M, Zatorski H, Timmermans JP, Bradshaw HB, Ahn K, Storr MA.

Neurogastroenterol Motil. 2014 Apr;26(4):470-81. doi: 10.1111/nmo.12272. Epub 2013 Dec 3.


Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.

Fichna J, Wood JT, Papanastasiou M, Vadivel SK, Oprocha P, Sałaga M, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Krajewska WM, Kościelniak P, Makriyannis A, Storr MA.

PLoS One. 2013 Dec 27;8(12):e85073. doi: 10.1371/journal.pone.0085073. eCollection 2013.


Eosinophilic colitis is a sporadic self-limited disease of middle-aged people: a population-based study.

Alfadda AA, Shaffer EA, Urbanski SJ, Storr MA.

Colorectal Dis. 2014 Feb;16(2):123-9. doi: 10.1111/codi.12464.


The association between celiac disease and eosinophilic esophagitis in children and adults.

Stewart MJ, Shaffer E, Urbanski SJ, Beck PL, Storr MA.

BMC Gastroenterol. 2013 May 30;13:96. doi: 10.1186/1471-230X-13-96.


Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013.

Storr MA.

ISRN Gastroenterol. 2013 Apr 18;2013:352718. doi: 10.1155/2013/352718. Print 2013.


Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity.

Klein S, Seidler B, Kettenberger A, Sibaev A, Rohn M, Feil R, Allescher HD, Vanderwinden JM, Hofmann F, Schemann M, Rad R, Storr MA, Schmid RM, Schneider G, Saur D.

Nat Commun. 2013;4:1630. doi: 10.1038/ncomms2626.


Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.

Sobczak M, Sałaga M, Storr MA, Fichna J.

J Gastroenterol. 2014 Jan;49(1):24-45. doi: 10.1007/s00535-013-0753-x. Epub 2013 Feb 9. Review.


New neostigmine-based behavioral mouse model of abdominal pain.

Fichna J, Lapointe T, Chapman K, Janecka A, Vergnolle N, Altier C, Storr MA.

Pharmacol Rep. 2012;64(5):1146-54.


Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?

Fichna J, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Janecka A, Krajewska WM, Storr MA.

Neurogastroenterol Motil. 2012 Nov;24(11):e557-60. doi: 10.1111/j.1365-2982.2012.01999.x. Epub 2012 Aug 10.


Brain-Gut Interactions in IBS.

Fichna J, Storr MA.

Front Pharmacol. 2012 Jul 5;3:127. doi: 10.3389/fphar.2012.00127. eCollection 2012.


Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling.

Hons IM, Storr MA, Mackie K, Lutz B, Pittman QJ, Mawe GM, Sharkey KA.

Neurogastroenterol Motil. 2012 Mar;24(3):e113-24. doi: 10.1111/j.1365-2982.2011.01860.x. Epub 2012 Jan 11.


Cytokines and irritable bowel syndrome: where do we stand?

Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NE, Sharkey KA, Storr MA.

Cytokine. 2012 Feb;57(2):201-9. doi: 10.1016/j.cyto.2011.11.019. Epub 2011 Dec 16. Review.


Eosinophilic colitis: an update on pathophysiology and treatment.

Alfadda AA, Storr MA, Shaffer EA.

Br Med Bull. 2011;100:59-72. doi: 10.1093/bmb/ldr045. Epub 2011 Oct 19. Review.


Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.

Fichna J, Dicay M, Lewellyn K, Janecka A, Zjawiony JK, MacNaughton WK, Storr MA.

Inflamm Bowel Dis. 2012 Jun;18(6):1137-45. doi: 10.1002/ibd.21873. Epub 2011 Sep 26.


Supplemental Content

Loading ...
Support Center